Over the last 40 years, twin packs of EpiPens became a fixture for people and parents with children experiencing severe allergic reactions.
Now, ARS Pharmaceuticals …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Dive Brief: Carmat has warned investors that it has enough money to fund operations only through the end of next month, creating a pressing need
BioXcel plans to lay off 110 workers, or 58% of its workforce, as part of a restructuring that aims to reduce the biotech’s cash burn.
Entrada Therapeutics announced that it completed dosing for two cohorts for a Phase I study of an experimental Duchenne muscular dystrophy drug that it’s conducting